| Patents for C12N 5 - Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor (182,629) |
|---|
| 06/25/1997 | CN1152875A Enhanced virus-mediated DNA transfer |
| 06/24/1997 | US5641875 Dna construct encoding immunoglobulin g fc receptor comprising extracellular, transmembrane and cytoplasmic domains or functional portions thereof, which renders phagocytic cell comprising same |
| 06/24/1997 | US5641869 Fractionation on immunoaffinity or ion exchange column, ethanol or ammonium sulfate precipitation, reverse phase liquid chromatography, chromatography on silica or heparin sepharose, chromatofocusing, gel filtration, electrophoresis |
| 06/24/1997 | US5641863 Immunoglobulin g fc receptor comprising extracellular, transmembrane and cytoplasmic domains or functional portions thereof, which renders phagocytic cells comprising same |
| 06/24/1997 | US5641860 A glycoprotein useful in the diagnosis of t-lymphoblastic lymphoma and leukemia |
| 06/24/1997 | US5641837 Method of detecting collagen degradation in vivo |
| 06/24/1997 | US5641756 Synthetic oligonucleotide complementary to nucleic acid specific for human vascular endothelial growth factor |
| 06/24/1997 | US5641749 Method for treating retinal ganglion cell injury using glial cell line-derived neurothrophic factor (GDNF) protein product |
| 06/24/1997 | US5641687 Contacting body fluid with immunological binding partner which binds to specified crosslinked collagen telopeptide, detecting binding, correlating with collagen degradation |
| 06/24/1997 | US5641678 Serum-free culture medium for drosphila insect cells |
| 06/24/1997 | US5641677 Method of enhancing the immunotherapeutic activity of immune cells by depletion of CD8+ T cells |
| 06/24/1997 | US5641676 Leukaemia inhibitory factor from livestock species and use thereof to enhance implantation and development of embryonic cells |
| 06/24/1997 | US5641673 Polynucleotide molecule encoding trans-splicing ribozyme with rna sequence hybridizing to target rna encoding transcription activator protein fused to sequence to be trans-spliced into target rna, linked to transcription regulator |
| 06/24/1997 | US5641670 Protein production and protein delivery |
| 06/24/1997 | US5641669 Platelet-activating factor acetylhydrolase |
| 06/24/1997 | US5641665 Plasmids suitable for IL-2 expression |
| 06/24/1997 | US5641664 Wounding or degrading type i callus and transferring dna into nuclear genome of corn cell |
| 06/24/1997 | US5641662 Transfection of lung via aerosolized transgene delivery |
| 06/24/1997 | US5641657 DNA encoding an interleukin-6 splice variant |
| 06/24/1997 | US5641655 Genetic engineered dna encoding a protein fusion |
| 06/24/1997 | US5641647 Serum free medium |
| 06/24/1997 | US5641638 Monoclonal antibodies against Mycoplasma pneumoniae, hybridomas producing these, methods for the preparation thereof, and the use thereof |
| 06/24/1997 | US5641622 Continuous centrifugation process for the separation of biological components from heterogeneous cell populations |
| 06/24/1997 | US5641497 Gastrointestinal defensins, cDNA sequences and method for the production and use thereof |
| 06/19/1997 | WO1997022002A1 Process and device for in vitro diagnosis of allergic disorders |
| 06/19/1997 | WO1997021826A2 Complementary adenoviral vector systems and cell lines |
| 06/19/1997 | WO1997021825A1 Method for obtaining retroviral packaging cell lines producing high transducing efficiency retroviral supernatant |
| 06/19/1997 | WO1997021824A2 Method for obtaining retroviral vector supernatant having high transduction efficiency |
| 06/19/1997 | WO1997021820A2 A novel protein kinase required for ras signal transduction |
| 06/19/1997 | WO1997021812A2 Mammalian chemokine ccf8 and chemokine receptor cckr3 |
| 06/19/1997 | WO1997021811A2 Novel tyrosine kinase receptors and ligands |
| 06/19/1997 | WO1997021803A1 Aldolase catalytic antibody |
| 06/19/1997 | WO1997021802A1 Novel embryonic cell populations and methods to isolate such populations |
| 06/19/1997 | WO1997021801A2 Production and screening process for phytochemical production by plant cell cultures |
| 06/19/1997 | WO1997021730A1 Growth hormone secretagogue receptor family |
| 06/19/1997 | WO1997021488A1 Cell separation composition, kit and method |
| 06/19/1997 | WO1997021447A1 Compositions and therapeutic methods using morphogenic proteins and stimulatory factors |
| 06/19/1997 | WO1997016549A3 Molecular cloning and characterization of molecules related to relaxin and the insulin family of ligands |
| 06/19/1997 | WO1997010796A3 MANIPULATION AND DETECTION OF PROTEIN PHOSPHATASE 2C - PP2Cα - EXPRESSION IN TUMOR CELLS FOR CANCER THERAPY, PREVENTION AND DETECTION |
| 06/19/1997 | WO1997006256A3 Isolated nucleic acid molecules useful as leukemia markers and in breast cancer prognosis |
| 06/19/1997 | WO1996024650A3 Cytoplasmic antiproteinase-2 and cytoplasmic antiproteinase-3 and coding sequences |
| 06/19/1997 | CA2557769A1 Plants having mutant sequences that confer altered fatty acid profiles |
| 06/19/1997 | CA2242929A1 Production and screening process for phytochemical production by plant cell cultures |
| 06/19/1997 | CA2238434A1 Method for obtaining retroviral vector supernatant having high transduction efficiency |
| 06/18/1997 | EP0779365A2 Methods to introduce nucleic acid into cells for therapeutic and diagnostic uses |
| 06/18/1997 | EP0779362A1 DNA constructs for endogenous gene activation and expression modification |
| 06/18/1997 | EP0779360A1 HYBRIDOMA THAT EXPRESSES mRNA OF INTERLEUKIN-5 AND METHOD OF SCREENING DRUGS THEREWITH |
| 06/18/1997 | EP0779359A1 Method of culturing avian cells and cell line obtained thereby |
| 06/18/1997 | EP0779024A2 A canola variety producing a seed with reduced glucosinolates and linolenic acid yielding an oil with low sulfur, improved sensory characteristics and increased oxidative stability |
| 06/18/1997 | EP0778944A1 Cell separation apparatus and method |
| 06/18/1997 | EP0778896A1 Nucleotides sequences of canola and soybean palmitoyl-acp thioesterase genes and their use in the regulation of fatty acid content of the oils of soybean and canola plants |
| 06/18/1997 | EP0778895A1 Ga4 dna, protein and methods of use |
| 06/18/1997 | EP0778892A1 Macrophage derived chemokine and chemokine analogs |
| 06/18/1997 | EP0778890A1 Dna encoding a human calcium channel alpha-1e subunit |
| 06/18/1997 | EP0778887A1 Rapid expansion method ("rem") for in vitro propagation of t lymphocytes |
| 06/18/1997 | EP0778886A1 Transgenic animal expressing a familial form of human amyloid precursor protein |
| 06/18/1997 | EP0778842A1 Mammalian telomerase |
| 06/18/1997 | EP0710110A4 Rapamycin conjugates and antibodies |
| 06/18/1997 | EP0610330B1 Monoclonal antibodies directed against the microtubule-associated protein tau |
| 06/18/1997 | EP0580635B1 Modified plant viruses as vectors |
| 06/18/1997 | EP0516845B1 Novel megakaryocytic colony stimulating factor and process for its preparation |
| 06/18/1997 | EP0512064B1 Extracellular segments of human ige immunoglobulin anchoring peptides and antibodies specific therefor |
| 06/18/1997 | EP0494264B1 Inhibiting transforming growth factor to prevent accumulation of extracellular matrix |
| 06/18/1997 | EP0447483B1 Dopamine receptors and genes |
| 06/18/1997 | CN1152251A Isolated nucleic acid sequence coding for a tumor rejection antigen presented by HLA-A2 |
| 06/18/1997 | CN1152029A P450 series of human cytochrome transgenosis cell strain |
| 06/17/1997 | US5639949 Genes for the synthesis of antipathogenic substances |
| 06/17/1997 | US5639948 Restoring fertility to plants |
| 06/17/1997 | US5639947 Genetic engineering |
| 06/17/1997 | US5639876 Encoding protein capable of selectively binding to immune serum which inhibits helminth development |
| 06/17/1997 | US5639872 Human VEGF-specific oligonucleotides |
| 06/17/1997 | US5639858 Polypeptide |
| 06/17/1997 | US5639856 Proteins that are modulators of nerve cell growth and regeneration |
| 06/17/1997 | US5639790 Plant medium-chain thioesterases |
| 06/17/1997 | US5639736 Reducing neovascularization by administering through the eye |
| 06/17/1997 | US5639730 Heating in presence of a tenside |
| 06/17/1997 | US5639725 Angiostatin protein |
| 06/17/1997 | US5639664 A transformant; genetic engineering |
| 06/17/1997 | US5639654 Process for creating a skin substitute and the resulting skin substitute |
| 06/17/1997 | US5639653 Method for proliferating Vγ2Vδ2 T cells |
| 06/17/1997 | US5639652 Nucleic acid encoding serotonin |
| 06/17/1997 | US5639638 DNA molecules encoding bone morpogenetic protein-11 |
| 06/17/1997 | US5639634 Useful for diagnosing tumors and targeting drug delivery |
| 06/17/1997 | US5639622 Monoclonal antibodies against tumor-associated antigens, a process for the preparation thereof and the use thereof |
| 06/17/1997 | US5639621 Immunoreactive with a polymorphic epithelial mucin antigen |
| 06/17/1997 | US5639619 Screening assay for anti-HIV drugs using the Vpr gene |
| 06/17/1997 | US5639618 Method of isolating a lineage specific stem cell in vitro |
| 06/17/1997 | US5639617 Determining concentration of procalcitonin in biological fluids to diagnose infections or monitor treatment |
| 06/17/1997 | US5639607 Digesting dna with restriction endonuclease which recognises the dna sequence at the site of polymorphism being able to cleave at the site ala-d2 of 5-aminolevulinate dehydrogenae gene which is not present in ala-d1 allele |
| 06/17/1997 | US5639605 Human interleukin-3 receptor component |
| 06/17/1997 | US5639599 Centrifuging, separating, lysing, exposing to sound waves, complexing and amplifying by polymerase chain reaction |
| 06/17/1997 | US5639467 Electrostatic process for manufacturing coated transplants and product |
| 06/17/1997 | US5639453 Therapeutic uses of IL-3 |
| 06/17/1997 | US5639275 Capsule containing genetically engineered cells |
| 06/16/1997 | CA2279675A1 Property effecting and/or property exhibiting constructs for localizing a nucleic acid construct within a cell for therapeutic and diagnostic uses |
| 06/16/1997 | CA2279673A1 Property effecting and/or property exhibiting constructs for the expression of non-native nucleic acids for therapeutic and diagnostic uses |
| 06/16/1997 | CA2279669A1 Property effecting and/or property exhibiting constructs for the expression of non-native nucleic acid processing components for therapeutic and diagnostic uses |
| 06/16/1997 | CA2192738A1 Truncated form of inhibitory kappa b protein (lkb), recombinant production and uses thereof |
| 06/16/1997 | CA2190304A1 Property effecting and/or property exhibiting compositions for therapeutic and diagnostic uses |
| 06/12/1997 | WO1997020943A1 Regulated protein expression in stably transfected mammalian cells |